The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study

R-Bendamustine is an effective treatment for follicular lymphoma (FL). Previous large trials demonstrated the prognostic role of the molecular minimal residual disease (MRD) during the most frequently adopted chemotherapeutic regimens, but there are not yet conclusive data about the effect of combin...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Pharmacol
Hlavní autoři: Galimberti, Sara, Ciabatti, Elena, Ercolano, Giacomo, Grassi, Susanna, Guerrini, Francesca, Cecconi, Nadia, Rousseau, Martina, Cervetti, Giulia, Mazziotta, Francesco, Iovino, Lorenzo, Falzetti, Franca, Falcinelli, Flavio, Bosi, Alberto, Rigacci, Luigi, Kovalchuk, Sofia, Vallisa, Daniele, Macchia, Lucia, Ciancia, Eugenio, Petrini, Mario
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2017
Témata:
Pharmacology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5489595/
https://ncbi.nlm.nih.gov/pubmed/28706485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00413
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky